{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:38:57Z","timestamp":1787020737824,"version":"build-2736575974"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07686-1","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T07:45:50Z","timestamp":1768031150000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Precision RNA interference of Smad3 and Runx2 via dual targeting nanocarriers mitigates aortic valve disease"],"prefix":"10.1186","volume":"24","author":[{"given":"Geanina","family":"Voicu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Ana","family":"Mocanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florentina","family":"Safciuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Anghelache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Turtoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Deleanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Simionescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ileana","family":"Manduteanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5245-160X","authenticated-orcid":false,"given":"Manuela","family":"Calin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"key":"7686_CR1","doi-asserted-by":"publisher","unstructured":"Timmis A, Vardas P, Townsend N, Torbica A, Katus H, De Smedt D, et al. European society of cardiology: cardiovascular disease statistics 2021. Eur Heart J. 2022;43. https:\/\/doi.org\/10.1093\/eurheartj\/ehab892.","DOI":"10.1093\/eurheartj\/ehab892"},{"key":"7686_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.783543","author":"NH Dayawansa","year":"2022","unstructured":"Dayawansa NH, Baratchi S, Peter K. Uncoupling the vicious cycle of mechanical stress and inflammation in calcific aortic valve disease. Front Cardiovasc Med. 2022. https:\/\/doi.org\/10.3389\/fcvm.2022.783543.","journal-title":"Front Cardiovasc Med"},{"key":"7686_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114775","author":"L Shu","year":"2023","unstructured":"Shu L, Yuan Z, Li F, Cai Z. Oxidative stress and valvular endothelial cells in aortic valve calcification. Biomed Pharmacotherapy. 2023. https:\/\/doi.org\/10.1016\/j.biopha.2023.114775.","journal-title":"Biomed Pharmacotherapy"},{"key":"7686_CR4","doi-asserted-by":"publisher","unstructured":"Gee TW, Richards JM, Mahmut A, Butcher JT. Valve endothelial-interstitial interactions drive emergent complex calcific lesion formation in vitro. Biomaterials. 2021;269. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.120669.","DOI":"10.1016\/j.biomaterials.2021.120669"},{"key":"7686_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.09.089","author":"JC Kovacic","year":"2019","unstructured":"Kovacic JC, Dimmeler S, Harvey RP, Finkel T, Aikawa E, Krenning G, et al. Endothelial to mesenchymal transition in cardiovascular disease: JACC State-of-the-Art review. J Am Coll Cardiol. 2019. https:\/\/doi.org\/10.1016\/j.jacc.2018.09.089.","journal-title":"J Am Coll Cardiol"},{"key":"7686_CR6","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.2353\/ajpath.2007.070251","volume":"171","author":"AC Liu","year":"2007","unstructured":"Liu AC, Joag VR, Gotlieb AI. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am J Pathol [Internet]. 2007;171:1407\u201318. https:\/\/doi.org\/10.2353\/ajpath.2007.070251.","journal-title":"Am J Pathol [Internet]"},{"key":"7686_CR7","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1161\/01.CIR.0000017435.87463.72","volume":"105","author":"NM Rajamannan","year":"2002","unstructured":"Rajamannan NM, Subramaniam M, Springett M, Sebo TC, Niekrasz M, McConnell JP, et al. Atorvastatin inhibits Hypercholesterolemia-Induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation. 2002;105:2660\u20135. https:\/\/doi.org\/10.1161\/01.CIR.0000017435.87463.72.","journal-title":"Circulation"},{"key":"7686_CR8","doi-asserted-by":"publisher","unstructured":"Mosch J, Gleissner CA, Body S, Aikawa E. Histopathological assessment of calcification and inflammation of calcific aortic valves from patients with and without diabetes mellitus. Histol Histopathol. 2017;32. https:\/\/doi.org\/10.14670\/HH-11-797.","DOI":"10.14670\/HH-11-797"},{"key":"7686_CR9","doi-asserted-by":"publisher","first-page":"e033872","DOI":"10.1161\/JAHA.123.033872","volume":"13","author":"X Jacquemyn","year":"2024","unstructured":"Jacquemyn X, Strom JB, Strange G, Playford D, Stewart S, Kutty S, et al. Moderate aortic valve stenosis is associated with increased mortality rate and lifetime loss: systematic review and Meta-Analysis of reconstructed Time\u2010to\u2010Event data of 409 680 patients. J Am Heart Assoc. 2024;13:e033872. https:\/\/doi.org\/10.1161\/JAHA.123.033872.","journal-title":"J Am Heart Assoc"},{"key":"7686_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccl.2019.09.010","author":"KH Zheng","year":"2020","unstructured":"Zheng KH, Tzolos E, Dweck MR. Pathophysiology of aortic stenosis and future perspectives for medical therapy. Cardiol Clin. 2020. https:\/\/doi.org\/10.1016\/j.ccl.2019.09.010.","journal-title":"Cardiol Clin"},{"key":"7686_CR11","doi-asserted-by":"publisher","first-page":"136355","DOI":"10.1016\/j.ijbiomac.2024.136355","volume":"281","author":"G Voicu","year":"2024","unstructured":"Voicu G, Mocanu CA, Safciuc F, Rebleanu D, Anghelache M, Cecoltan S, et al. VCAM-1 targeted nanocarriers of shRNA-Smad3 mitigate endothelial-to-mesenchymal transition triggered by high glucose concentrations and osteogenic factors in valvular endothelial cells. Int J Biol Macromol. 2024;281:136355. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.136355.","journal-title":"Int J Biol Macromol"},{"key":"7686_CR12","doi-asserted-by":"publisher","unstructured":"Voicu G, Mocanu CA, Safciuc F, Anghelache M, Deleanu M, Cecoltan S, et al. Nanocarriers of shRNA-Runx2 directed to collagen IV as a nanotherapeutic system to target calcific aortic valve disease. Mater Today Bio. 2023;20. https:\/\/doi.org\/10.1016\/j.mtbio.2023.100620.","DOI":"10.1016\/j.mtbio.2023.100620"},{"key":"7686_CR13","doi-asserted-by":"publisher","unstructured":"Mo X, Yan F, Zhang B. Molecular ultrasound monitoring of early artery injury after carotid balloon angioplasty. Front Pharmacol. 2019;9. https:\/\/doi.org\/10.3389\/fphar.2018.01569.","DOI":"10.3389\/fphar.2018.01569"},{"key":"7686_CR14","doi-asserted-by":"publisher","DOI":"10.1080\/10739680590925484","author":"J Chen","year":"2005","unstructured":"Chen J, L\u00f3pez JA. Interactions of platelets with subendothelium and endothelium. Microcirculation. 2005. https:\/\/doi.org\/10.1080\/10739680590925484.","journal-title":"Microcirculation"},{"key":"7686_CR15","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.3390\/ijms23073824","volume":"23","author":"G Voicu","year":"2022","unstructured":"Voicu G, Rebleanu D, Mocanu CA, Tanko G, Droc I, Uritu CM, et al. VCAM-1 targeted lipopolyplexes as vehicles for efficient delivery of shRNA-Runx2 to Osteoblast-Differentiated valvular interstitial Cells; implications in calcific valve disease treatment. Int J Mol Sci. 2022;23:3824\u201347. https:\/\/doi.org\/10.3390\/ijms23073824.","journal-title":"Int J Mol Sci"},{"key":"7686_CR16","doi-asserted-by":"publisher","unstructured":"Bofinger R, Zaw-Thin M, Mitchell NJ, Patrick PS, Stowe C, Gomez-Ramirez A, et al. Development of lipopolyplexes for gene delivery: A comparison of the effects of differing modes of targeting peptide display on the structure and transfection activities of lipopolyplexes. J Pept Sci. 2018;24. https:\/\/doi.org\/10.1002\/psc.3131.","DOI":"10.1002\/psc.3131"},{"key":"7686_CR17","doi-asserted-by":"publisher","first-page":"103215","DOI":"10.1016\/j.redox.2024.103215","volume":"73","author":"C Jiang","year":"2024","unstructured":"Jiang C, Yao D, Liu Z, Zheng Y, Chen M, Yim WY, et al. FOXO1 regulates RUNX2 ubiquitination through SMURF2 in calcific aortic valve disease. Redox Biol. 2024;73:103215. https:\/\/doi.org\/10.1016\/j.redox.2024.103215.","journal-title":"Redox Biol"},{"key":"7686_CR18","doi-asserted-by":"publisher","unstructured":"Xiong J, Lin W, Yuan C, Bian J, Diao Y, Xu X, et al. SIRT6-mediated Runx2 downregulation inhibits osteogenic differentiation of human aortic valve interstitial cells in calcific aortic valve disease. Eur J Pharmacol. 2024;968. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176423.","DOI":"10.1016\/j.ejphar.2024.176423"},{"key":"7686_CR19","doi-asserted-by":"publisher","unstructured":"Liu Z, Wang Y, Liu F, Zhu D, Chen Y, Yim WY, et al. Long noncoding TSI attenuates aortic valve calcification by suppressing TGF-\u03b21-induced osteoblastic differentiation of valve interstitial cells. Metabolism. 2023;138. https:\/\/doi.org\/10.1016\/j.metabol.2022.155337.","DOI":"10.1016\/j.metabol.2022.155337"},{"key":"7686_CR20","doi-asserted-by":"publisher","unstructured":"Yoon D, Choi B, Kim JE, Kim EY, Chung SH, Min HJ, et al. Autotaxin Inhibition attenuates the aortic valve calcification by suppressing inflammation-driven fibro-calcific remodeling of valvular interstitial cells. BMC Med. 2024;22. https:\/\/doi.org\/10.1186\/s12916-024-03342-x.","DOI":"10.1186\/s12916-024-03342-x"},{"key":"7686_CR21","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.jtcvs.2014.02.084","volume":"148","author":"X-W Zhang","year":"2014","unstructured":"Zhang X-W, Zhang B-Y, Wang S-W, Gong D-J, Han L, Xu Z-Y, et al. Twist-related protein 1 negatively regulated osteoblastic transdifferentiation of human aortic valve interstitial cells by directly inhibiting runt-related transcription factor 2. J Thorac Cardiovasc Surg. 2014;148:1700\u2013e17081. https:\/\/doi.org\/10.1016\/j.jtcvs.2014.02.084.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"7686_CR22","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1177\/1479164119874469","volume":"16","author":"MM Tucureanu","year":"2019","unstructured":"Tucureanu MM, Filippi A, Alexandru N, Ana Constantinescu C, Ciortan L, Macarie R, et al. Diabetes-induced early molecular and functional changes in aortic heart valves in a murine model of atherosclerosis. Diab Vasc Dis Res. 2019;16:562\u201376. https:\/\/doi.org\/10.1177\/1479164119874469.","journal-title":"Diab Vasc Dis Res"},{"key":"7686_CR23","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.jconrel.2021.09.012","volume":"338","author":"CA Mocanu","year":"2021","unstructured":"Mocanu CA, Fuior EV, Voicu G, Rebleanu D, Safciuc F, Deleanu M, et al. P-selectin targeted RAGE-shRNA lipoplexes alleviate atherosclerosis-associated inflammation. J Controlled Release. 2021;338:754\u201372. https:\/\/doi.org\/10.1016\/j.jconrel.2021.09.012.","journal-title":"J Controlled Release"},{"key":"7686_CR24","doi-asserted-by":"publisher","DOI":"10.1113\/JP280389","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. J Physiol. 2020. https:\/\/doi.org\/10.1113\/JP280389.","journal-title":"J Physiol"},{"key":"7686_CR25","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1039\/C4TB02040E","volume":"3","author":"CM Uritu","year":"2015","unstructured":"Uritu CM, Varganici CD, Ursu L, Coroaba A, Nicolescu A, Dascalu AI, et al. Hybrid fullerene conjugates as vectors for DNA cell-delivery. J Mater Chem B. 2015;3:2433\u201346. https:\/\/doi.org\/10.1039\/C4TB02040E.","journal-title":"J Mater Chem B"},{"key":"7686_CR26","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.3390\/pharmaceutics12111066","volume":"12","author":"EV Fuior","year":"2020","unstructured":"Fuior EV, Mocanu CA, Deleanu M, Voicu G, Anghelache M, Rebleanu D, et al. Evaluation of VCAM-1 targeted Naringenin\/Indocyanine Green-Loaded lipid nanoemulsions as theranostic nanoplatforms in inflammation. Pharmaceutics. 2020;12:1066. https:\/\/doi.org\/10.3390\/pharmaceutics12111066.","journal-title":"Pharmaceutics"},{"key":"7686_CR27","doi-asserted-by":"publisher","unstructured":"Titorencu I, Jinga VV, Constantinescu E, Gafencu AV, Ciohodaru C, Manolescu I, et al. Proliferation, differentiation and characterization of osteoblasts from human BM mesenchymal cells. Cytotherapy. 2007;9. https:\/\/doi.org\/10.1080\/14653240701561329.","DOI":"10.1080\/14653240701561329"},{"key":"7686_CR28","doi-asserted-by":"publisher","unstructured":"Jeon EJ, Lee KY, Choi NS, Lee MH, Kim HN, Jin YH, et al. Bone morphogenetic protein-2 stimulates Runx2 acetylation. J Biol Chem. 2006;281. https:\/\/doi.org\/10.1074\/jbc.M512494200.","DOI":"10.1074\/jbc.M512494200"},{"key":"7686_CR29","doi-asserted-by":"publisher","unstructured":"Masuda T, Wan J, Yerrabelli A, Berlinicke C, Kallman A, Qian J, et al. Off target, but sequence-Specific, shRNA-Associated trans-Activation of promoter reporters in transient transfection assays. PLoS ONE. 2016;11. https:\/\/doi.org\/10.1371\/journal.pone.0167867.","DOI":"10.1371\/journal.pone.0167867"},{"key":"7686_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab757","author":"S Kraler","year":"2022","unstructured":"Kraler S, Blaser MC, Aikawa E, Camici GG, L\u00fcscher TF. Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy. Eur Heart J. 2022. https:\/\/doi.org\/10.1093\/eurheartj\/ehab757.","journal-title":"Eur Heart J"},{"key":"7686_CR31","unstructured":"Study Investigating the Effect of. Drugs used to treat osteoporosis on the progression of calcific aortic stenosis. (SALTIRE II)."},{"key":"7686_CR32","doi-asserted-by":"publisher","DOI":"10.1586\/14779072.2015.1037284","author":"TA Pawade","year":"2015","unstructured":"Pawade TA, Newby DE. Treating aortic stenosis: arresting the snowball effect. Expert Rev Cardiovasc Ther. 2015. https:\/\/doi.org\/10.1586\/14779072.2015.1037284.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"7686_CR33","doi-asserted-by":"publisher","unstructured":"Pawade TA, Doris MK, Bing R, White AC, Forsyth L, Evans E, et al. Effect of denosumab or alendronic acid on the progression of aortic stenosis: A Double-Blind randomized controlled trial. Circulation. 2021;143. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.053708.","DOI":"10.1161\/CIRCULATIONAHA.121.053708"},{"key":"7686_CR34","unstructured":"Angiotensin. Receptor Blockers in Aortic Stenosis (ARBAS)."},{"key":"7686_CR35","doi-asserted-by":"publisher","unstructured":"C\u00f4t\u00e9 N, Mahmut A, Fournier D, Boulanger MC, Couture C, Despr\u00e9s JP, et al. Angiotensin receptor blockers are associated with reduced fibrosis and interleukin-6 expression in calcific aortic valve disease. Pathobiology. 2013;81. https:\/\/doi.org\/10.1159\/000350896.","DOI":"10.1159\/000350896"},{"key":"7686_CR36","doi-asserted-by":"publisher","unstructured":"Dharmarajan S, Speer MY, Pierce K, Lally J, Leaf EM, Lin M-E, et al. Role of Runx2 in calcific aortic valve disease in mouse models. Front Cardiovasc Med. 2021;8. https:\/\/doi.org\/10.3389\/fcvm.2021.687210.","DOI":"10.3389\/fcvm.2021.687210"},{"key":"7686_CR37","doi-asserted-by":"publisher","unstructured":"Chakrabarti M, Bhattacharya A, Gebere MG, Johnson J, Ayub ZA, Chatzistamou I, et al. Increased TGF\u03b21 and SMAD3 contribute to Age-Related aortic valve calcification. Front Cardiovasc Med. 2022;9. https:\/\/doi.org\/10.3389\/fcvm.2022.770065.","DOI":"10.3389\/fcvm.2022.770065"},{"key":"7686_CR38","doi-asserted-by":"publisher","unstructured":"Jiang Y, Zhu J, Chen Z, Wang W, Cao Z, Chen X, et al. CircRNA ARHGAP10 promotes osteogenic differentiation through the miR-335-3p\/RUNX2 pathway in aortic valve calcification. J Thorac Dis. 2023;15. https:\/\/doi.org\/10.21037\/jtd-23-919.","DOI":"10.21037\/jtd-23-919"},{"key":"7686_CR39","doi-asserted-by":"publisher","unstructured":"Tsai HY, Wang JC, Hsu YJ, Chiu YL, Lin CY, Lu CY, et al. miR-424\/322 protects against abdominal aortic aneurysm formation by modulating the Smad2\/3\/runt-related transcription factor 2 axis. Mol Ther Nucleic Acids. 2022;27. https:\/\/doi.org\/10.1016\/j.omtn.2021.12.028.","DOI":"10.1016\/j.omtn.2021.12.028"},{"key":"7686_CR40","doi-asserted-by":"publisher","unstructured":"Afzal F, Pratap J, Ito K, Ito Y, Stein JL, Van Wijnen AJ, et al. Smad function and intranuclear targeting share a Runx2 motif required for osteogenic lineage induction and BMP2 responsive transcription. J Cell Physiol. 2005;204. https:\/\/doi.org\/10.1002\/jcp.20258.","DOI":"10.1002\/jcp.20258"},{"key":"7686_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-7207(01)00524-X","author":"L Attisano","year":"2001","unstructured":"Attisano L, Silvestri C, Izzi L, Labb\u00e9 E. The transcriptional role of Smads and FAST (FoxH1) in TGF\u03b2 and activin signalling. Mol Cell Endocrinol. 2001. https:\/\/doi.org\/10.1016\/S0303-7207(01)00524-X.","journal-title":"Mol Cell Endocrinol"},{"key":"7686_CR42","doi-asserted-by":"publisher","unstructured":"Fang M, Wang CG, Zheng C, Luo J, Hou S, Liu K, et al. Mir-29b promotes human aortic valve interstitial cell calcification via inhibiting TGF-\u03b23 through activation of wnt3\/\u03b2-catenin\/Smad3 signaling. J Cell Biochem. 2018;119. https:\/\/doi.org\/10.1002\/jcb.26545.","DOI":"10.1002\/jcb.26545"},{"key":"7686_CR43","doi-asserted-by":"publisher","unstructured":"Javed A, Bae JS, Afza F, Gutierrez S, Pratap J, Zaidi SK, et al. Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal. J Biol Chem. 2008;283. https:\/\/doi.org\/10.1074\/jbc.M705578200.","DOI":"10.1074\/jbc.M705578200"},{"key":"7686_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2017.60","author":"M Haarhaus","year":"2017","unstructured":"Haarhaus M, Brandenburg V, Kalantar-Zadeh K, Stenvinkel P, Magnusson P. Alkaline phosphatase: A novel treatment target for cardiovascular disease in CKD. Nat Rev Nephrol. 2017. https:\/\/doi.org\/10.1038\/nrneph.2017.60.","journal-title":"Nat Rev Nephrol"},{"key":"7686_CR45","doi-asserted-by":"publisher","unstructured":"Webber M, Krishnan A, Thomas NG, Cheung BMY. Association between serum alkaline phosphatase and C-reactive protein in the united States National health and nutrition examination survey 2005\u20132006. Clin Chem Lab Med. 2010;48. https:\/\/doi.org\/10.1515\/CCLM.2010.052.","DOI":"10.1515\/CCLM.2010.052"},{"key":"7686_CR46","doi-asserted-by":"publisher","unstructured":"Guo J, Zeng M, Zhang Y, Huang H, Yang G, Xu F, et al. Serum alkaline phosphatase level predicts cardiac valve calcification in maintenance Hemodialysis patients. Blood Purif. 2020;49. https:\/\/doi.org\/10.1159\/000505846.","DOI":"10.1159\/000505846"},{"key":"7686_CR47","doi-asserted-by":"publisher","DOI":"10.1097\/j.pbj.0000000000000193","author":"JPL Nunes","year":"2022","unstructured":"Nunes JPL. Plasma alkaline phosphatase is associated with mortality risk in patients with aortic valve stenosis. Porto Biomed J. 2022. https:\/\/doi.org\/10.1097\/j.pbj.0000000000000193. 7.","journal-title":"Porto Biomed J"},{"key":"7686_CR48","doi-asserted-by":"publisher","unstructured":"Haarhaus M, Ray KK, Nicholls SJ, Schwartz GG, Kulikowski E, Johansson JO, et al. Apabetalone lowers serum alkaline phosphatase and improves cardiovascular risk in patients with cardiovascular disease. Atherosclerosis. 2019;290. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.09.002.","DOI":"10.1016\/j.atherosclerosis.2019.09.002"},{"key":"7686_CR49","doi-asserted-by":"publisher","unstructured":"Polonskaya YV, Kashtanova EV, Murashov IS, Volkov AM, Kurguzov AV, Chernyavsky AM, et al. Associations of osteocalcin, osteoprotegerin, and calcitonin with inflammation biomarkers in atherosclerotic plaques of coronary arteries. Bull Exp Biol Med. 2017;162. https:\/\/doi.org\/10.1007\/s10517-017-3698-x.","DOI":"10.1007\/s10517-017-3698-x"},{"key":"7686_CR50","doi-asserted-by":"publisher","unstructured":"Reyes-Garcia R, Rozas-Moreno P, Jimenez-Moleon JJ, Villoslada MJL, Garcia-Salcedo JA, Santana-Morales S, et al. Relationship between serum levels of osteocalcin and atherosclerotic disease in type 2 diabetes. Diabetes Metab. 2012;38. https:\/\/doi.org\/10.1016\/j.diabet.2011.07.008.","DOI":"10.1016\/j.diabet.2011.07.008"},{"key":"7686_CR51","doi-asserted-by":"publisher","unstructured":"Goliasch G, Blessberger H, Azar D, Heinze G, Wojta J, Bieglmayer C, et al. Markers of bone metabolism in premature myocardial infarction (\u2264\u200940years of age). Bone. 2011;48. https:\/\/doi.org\/10.1016\/j.bone.2010.11.005.","DOI":"10.1016\/j.bone.2010.11.005"},{"key":"7686_CR52","doi-asserted-by":"publisher","unstructured":"Bao Y, Zhou M, Lu Z, Li H, Wang Y, Sun L, et al. Serum levels of osteocalcin are inversely associated with the metabolic syndrome and the severity of coronary artery disease in Chinese men. Clin Endocrinol (Oxf). 2011;75. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04065.x.","DOI":"10.1111\/j.1365-2265.2011.04065.x"},{"key":"7686_CR53","doi-asserted-by":"publisher","unstructured":"Xu Y, Ma X, Xiong Q, Zhang X, Shen Y, Bao Y. Osteocalcin value to identify subclinical atherosclerosis over atherosclerotic cardiovascular disease (ASCVD) risk score in middle-aged and elderly Chinese asymptomatic men. Clin Chem Lab Med. 2018;56. https:\/\/doi.org\/10.1515\/cclm-2018-0320.","DOI":"10.1515\/cclm-2018-0320"},{"key":"7686_CR54","doi-asserted-by":"publisher","unstructured":"Kim KJ, Kim KM, Park KH, Choi HS, Rhee Y, Lee YH, et al. Aortic calcification and bone metabolism: the relationship between aortic calcification, BMD, vertebral fracture, 25-hydroxyvitamin D, and osteocalcin. Calcif Tissue Int. 2012;91. https:\/\/doi.org\/10.1007\/s00223-012-9642-1.","DOI":"10.1007\/s00223-012-9642-1"},{"key":"7686_CR55","doi-asserted-by":"publisher","unstructured":"Teplyuk NM, Zhang Y, Lou Y, Hawse JR, Hassan MQ, Teplyuk VI, et al. The osteogenic transcription factor Runx2 controls genes involved in sterol\/steroid metabolism, including Cyp11a1 in osteoblasts. Mol Endocrinol. 2009;23. https:\/\/doi.org\/10.1210\/me.2008-0270.","DOI":"10.1210\/me.2008-0270"},{"key":"7686_CR56","doi-asserted-by":"publisher","unstructured":"Bagnati M, Moreno-Moral A, Ko JH, Nicod J, Harmston N, Imprialou M, et al. Systems genetics identifies a macrophage cholesterol network associated with physiological wound healing. JCI Insight. 2019;4. https:\/\/doi.org\/10.1172\/jci.insight.125736.","DOI":"10.1172\/jci.insight.125736"},{"key":"7686_CR57","doi-asserted-by":"publisher","DOI":"10.1159\/000324763","author":"M Adhami","year":"2011","unstructured":"Adhami M, Ghori-Javed FY, Chen H, Gutierrez SE, Javed A. Runx2 regulates the gene network associated with insulin signaling and energy homeostasis. Cells Tissues Organs. 2011. https:\/\/doi.org\/10.1159\/000324763.","journal-title":"Cells Tissues Organs"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07686-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07686-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07686-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T15:28:02Z","timestamp":1770391682000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07686-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7686"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07686-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"9 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All Institutional and National Guidelines for the care and use of animals were followed. The experiments were approved by the Ethics Committee of the Institute of Cellular Biology and Pathology \u201cNicolae Simionescu\u201d and by the National Sanitary Veterinary and Food Safety Authority, authorization no. 448\/ 02.04.2019 and were performed according to the Romanian Law no. 43\/2014 (Official Monitor, Part I nr. 326, pages 2\u20134), which transposes the EU directive 2010\/63\/EU on the protection of animals used for scientific purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"157"}}